Corcept Therapeutics (CORT) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $81.13 +1.60%
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -96.6%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.14, $0.10 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $103.1 million versus the consensus estimate of $105.08 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- KB Home (KBH) PT Raised to $56 at Truist Securities
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
